Recent Findings GLP-1 agonists may be associated with breast changes and symptoms that warrant further breast imaging, including supplemental screening and/or for problem solving in the appropriate clinical scenario
Ozempic and Wegovy (semaglutide): what the data actually shows Semaglutide the active ingredient in both Ozempic and Wegovy also delays gastric emptying, but less and for a shorter time than Mounjaro/Zepbound/tirzepatide, and the drug-interaction studies show that
Effect of Vitamin D Supplementation, Omega-3 Fatty Acid Supplementation, or a Strength-Training Exercise Program on Clinical Outcomes in Older Adults: The DO-HEALTH Randomized Clinical Trial
its use rests on animal data and mechanistic reasoning
MEDVis program is open to adults who meet standard medical criteria for GLP-1 treatment
Antioxidant activation: GHK-Cu upregulates superoxide dismutase and other antioxidant enzymes, reducing oxidative damage from sun, pollution, and cellular aging